GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » E10

Sartorius Stedim Biotech (STU:56S1) E10 : €3.57 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Sartorius Stedim Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €3.57 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Sartorius Stedim Biotech's average E10 Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-21), Sartorius Stedim Biotech's current stock price is €193.80. Sartorius Stedim Biotech's E10 for the quarter that ended in Dec. 2023 was €3.57. Sartorius Stedim Biotech's Shiller PE Ratio of today is 54.29.

During the past 13 years, the highest Shiller PE Ratio of Sartorius Stedim Biotech was 131.04. The lowest was 46.50. And the median was 76.12.


Sartorius Stedim Biotech E10 Historical Data

The historical data trend for Sartorius Stedim Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech E10 Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.32 3.57

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 3.62 3.54 3.56 3.57

Competitive Comparison of Sartorius Stedim Biotech's E10

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Shiller PE Ratio falls into.



Sartorius Stedim Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.43/123.7729*123.7729
=0.430

Current CPI (Dec. 2023) = 123.7729.

Sartorius Stedim Biotech Quarterly Data

per share eps CPI Adj_EPS
201012 0.230 94.132 0.302
201106 0.103 95.158 0.134
201112 0.247 95.998 0.318
201206 0.130 96.744 0.166
201212 0.338 97.957 0.427
201306 0.223 98.516 0.280
201312 0.347 99.356 0.432
201406 0.212 99.543 0.264
201412 0.407 99.543 0.506
201506 0.350 100.417 0.431
201512 0.720 99.717 0.894
201606 0.430 100.717 0.528
201612 0.850 101.217 1.039
201706 0.420 102.117 0.509
201709 0.400 102.717 0.482
201712 0.490 102.617 0.591
201803 0.440 102.917 0.529
201806 0.540 104.017 0.643
201809 0.540 104.718 0.638
201812 0.740 104.217 0.879
201903 0.610 104.217 0.724
201906 0.700 105.718 0.820
201909 0.630 106.018 0.736
201912 0.590 105.818 0.690
202003 0.810 105.718 0.948
202006 0.720 106.618 0.836
202009 1.080 105.818 1.263
202012 1.030 105.518 1.208
202103 1.360 107.518 1.566
202106 1.610 108.486 1.837
202109 1.610 109.435 1.821
202112 -0.090 110.384 -0.101
202203 2.930 113.968 3.182
202206 2.330 115.760 2.491
202209 2.180 118.818 2.271
202212 2.070 119.345 2.147
202303 1.210 122.402 1.224
202306 1.440 123.140 1.447
202309 0.280 124.195 0.279
202312 0.430 123.773 0.430

Add all the adjusted EPS together and divide 10 will get our e10.


Sartorius Stedim Biotech  (STU:56S1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sartorius Stedim Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=193.80/3.57
=54.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sartorius Stedim Biotech was 131.04. The lowest was 46.50. And the median was 76.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sartorius Stedim Biotech E10 Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (STU:56S1) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech (STU:56S1) Headlines

No Headlines